Transcription factor CASZ1 increases an oncogenic transcriptional process in tumorigenesis and progression of glioma cells

Abstract As a transcription factor, the role of CASZ1 in different entities is inconsistent. Glioma is one of the leading causes of cancer death worldwide. Its prognostic relevance and biological functions in glioma remain obscure. We focused on the role, mechanism, and prognostic value of CASZ1 in...

Full description

Bibliographic Details
Main Authors: Chaofu Mao, Chengying Huang, Zhicheng Hu, Shanqiang Qu
Format: Article
Language:English
Published: Wiley 2022-12-01
Series:MedComm
Subjects:
Online Access:https://doi.org/10.1002/mco2.182
_version_ 1811300584454619136
author Chaofu Mao
Chengying Huang
Zhicheng Hu
Shanqiang Qu
author_facet Chaofu Mao
Chengying Huang
Zhicheng Hu
Shanqiang Qu
author_sort Chaofu Mao
collection DOAJ
description Abstract As a transcription factor, the role of CASZ1 in different entities is inconsistent. Glioma is one of the leading causes of cancer death worldwide. Its prognostic relevance and biological functions in glioma remain obscure. We focused on the role, mechanism, and prognostic value of CASZ1 in glioma cells. Herein, CASZ1 was identified as a novel potential oncogene in glioma tissues from GEO and TCGA datasets. CASZ1 was highly expressed in glioma tissues, predicting poor prognosis in glioma patients. Knockdown of CASZ1 inhibited proliferation and invasion in vitro, whereas upregulation of CASZ1 presented opposite results. Overexpression of CASZ1 increased transcriptional process of target gene p75NTR. CASZ1 was the potential transcriptional regulators for p75NTR. In addition, the p75NTR expression is essential for CASZ1 to exert its function as an oncogene. Our findings indicate that highly expressed CASZ1 in glioma cells acts as a pro‐oncogene factor in gliomas via regulating transcriptional process of target gene p75NTR, which was identified as an unfavorable prognostic marker in patients with gliomas. CASZ1 is expected to become a novel target for the treatment of gliomas.
first_indexed 2024-04-13T06:53:26Z
format Article
id doaj.art-b70c1baa14014694b891d609ba61a842
institution Directory Open Access Journal
issn 2688-2663
language English
last_indexed 2024-04-13T06:53:26Z
publishDate 2022-12-01
publisher Wiley
record_format Article
series MedComm
spelling doaj.art-b70c1baa14014694b891d609ba61a8422022-12-22T02:57:20ZengWileyMedComm2688-26632022-12-0134n/an/a10.1002/mco2.182Transcription factor CASZ1 increases an oncogenic transcriptional process in tumorigenesis and progression of glioma cellsChaofu Mao0Chengying Huang1Zhicheng Hu2Shanqiang Qu3Department of Neurosurgery Nanfang Hospital Southern Medical University Guangzhou Guangdong People's Republic of ChinaDepartment of Obstetrics and Gynecology, Baiyun Branch Nanfang Hospital Southern Medical University Guangzhou Guangdong People's Republic of ChinaDepartment of Burn Surgery First Affiliated Hospital Sun Yat‐sen University Guangzhou Guangdong People's Republic of ChinaDepartment of Neurosurgery Nanfang Hospital Southern Medical University Guangzhou Guangdong People's Republic of ChinaAbstract As a transcription factor, the role of CASZ1 in different entities is inconsistent. Glioma is one of the leading causes of cancer death worldwide. Its prognostic relevance and biological functions in glioma remain obscure. We focused on the role, mechanism, and prognostic value of CASZ1 in glioma cells. Herein, CASZ1 was identified as a novel potential oncogene in glioma tissues from GEO and TCGA datasets. CASZ1 was highly expressed in glioma tissues, predicting poor prognosis in glioma patients. Knockdown of CASZ1 inhibited proliferation and invasion in vitro, whereas upregulation of CASZ1 presented opposite results. Overexpression of CASZ1 increased transcriptional process of target gene p75NTR. CASZ1 was the potential transcriptional regulators for p75NTR. In addition, the p75NTR expression is essential for CASZ1 to exert its function as an oncogene. Our findings indicate that highly expressed CASZ1 in glioma cells acts as a pro‐oncogene factor in gliomas via regulating transcriptional process of target gene p75NTR, which was identified as an unfavorable prognostic marker in patients with gliomas. CASZ1 is expected to become a novel target for the treatment of gliomas.https://doi.org/10.1002/mco2.182CASZ1gliomatherapeutic targets
spellingShingle Chaofu Mao
Chengying Huang
Zhicheng Hu
Shanqiang Qu
Transcription factor CASZ1 increases an oncogenic transcriptional process in tumorigenesis and progression of glioma cells
MedComm
CASZ1
glioma
therapeutic targets
title Transcription factor CASZ1 increases an oncogenic transcriptional process in tumorigenesis and progression of glioma cells
title_full Transcription factor CASZ1 increases an oncogenic transcriptional process in tumorigenesis and progression of glioma cells
title_fullStr Transcription factor CASZ1 increases an oncogenic transcriptional process in tumorigenesis and progression of glioma cells
title_full_unstemmed Transcription factor CASZ1 increases an oncogenic transcriptional process in tumorigenesis and progression of glioma cells
title_short Transcription factor CASZ1 increases an oncogenic transcriptional process in tumorigenesis and progression of glioma cells
title_sort transcription factor casz1 increases an oncogenic transcriptional process in tumorigenesis and progression of glioma cells
topic CASZ1
glioma
therapeutic targets
url https://doi.org/10.1002/mco2.182
work_keys_str_mv AT chaofumao transcriptionfactorcasz1increasesanoncogenictranscriptionalprocessintumorigenesisandprogressionofgliomacells
AT chengyinghuang transcriptionfactorcasz1increasesanoncogenictranscriptionalprocessintumorigenesisandprogressionofgliomacells
AT zhichenghu transcriptionfactorcasz1increasesanoncogenictranscriptionalprocessintumorigenesisandprogressionofgliomacells
AT shanqiangqu transcriptionfactorcasz1increasesanoncogenictranscriptionalprocessintumorigenesisandprogressionofgliomacells